Statin use vs. average non-HDL cholesterol levels in Syria
Syria: Statin use vs. average non-HDL cholesterol levels was 3.4 in 2018. ▬ Flat
Statin use vs. average non-HDL cholesterol levels in Syria, 1980–2018
Source: World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
In 2018, statin use vs. average non-hdl cholesterol levels in Syria stood at 3.4.
That represents a change of down 5.6% over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Syria peaked at 3.7 in 1998 and was at its lowest, 3.3, in 1980.
That places Syria 75th out of 191 countries with data for 2018, putting it in the middle of the range.
Statin use vs. average non-HDL cholesterol levels in Syria, year by year
| Year | Value | Change |
|---|---|---|
| 1980 | 3.3 | — |
| 1981 | 3.4 | +3.0% |
| 1982 | 3.4 | +0.0% |
| 1983 | 3.4 | +0.0% |
| 1984 | 3.4 | +0.0% |
| 1985 | 3.5 | +2.9% |
| 1986 | 3.5 | +0.0% |
| 1987 | 3.5 | +0.0% |
| 1988 | 3.5 | +0.0% |
| 1989 | 3.5 | +0.0% |
| 1990 | 3.5 | +0.0% |
| 1991 | 3.6 | +2.9% |
| 1992 | 3.6 | +0.0% |
| 1993 | 3.6 | +0.0% |
| 1994 | 3.6 | +0.0% |
| 1995 | 3.6 | +0.0% |
| 1996 | 3.6 | +0.0% |
| 1997 | 3.6 | +0.0% |
| 1998 | 3.7 | +2.8% |
| 1999 | 3.7 | +0.0% |
| 2000 | 3.7 | +0.0% |
| 2001 | 3.7 | +0.0% |
| 2002 | 3.7 | +0.0% |
| 2003 | 3.6 | -2.7% |
| 2004 | 3.6 | +0.0% |
| 2005 | 3.6 | +0.0% |
| 2006 | 3.6 | +0.0% |
| 2007 | 3.6 | +0.0% |
| 2008 | 3.6 | +0.0% |
| 2009 | 3.6 | +0.0% |
| 2010 | 3.6 | +0.0% |
| 2011 | 3.5 | -2.8% |
| 2012 | 3.5 | +0.0% |
| 2013 | 3.5 | +0.0% |
| 2014 | 3.5 | +0.0% |
| 2015 | 3.5 | +0.0% |
| 2016 | 3.4 | -2.9% |
| 2017 | 3.4 | +0.0% |
| 2018 | 3.4 | +0.0% |
Syria compared with similar countries
- Syria's 3.4 is above the median for low income countries, which is 2.85, 1.2× the median. (24 countries reporting)
- Syria's 3.4 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 3.35, 1.0× the median. (22 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 3.44 | 3.3 | 3.5 | 10 |
| 1990s | 3.61 | 3.5 | 3.7 | 10 |
| 2000s | 3.63 | 3.6 | 3.7 | 10 |
| 2010s | 3.48 | 3.4 | 3.6 | 9 |
Countries ranked near Syria
- 75 Argentina 3.4 compare
- 75 Belize 3.4 compare
- 75 Brazil 3.4 compare
- 75 Chile 3.4 compare
- 75 Germany 3.4 compare
- 75 Israel 3.4 compare
- 75 Japan 3.4 compare
- 75 New Zealand 3.4 compare
- 75 Nicaragua 3.4 compare
- 75 Niue 3.4 compare
- 75 North Korea 3.4 compare
- 75 Oman 3.4 compare
- 75 Peru 3.4 compare
- 75 Saudi Arabia 3.4 compare
- 75 South Korea 3.4 compare
- 75 Sweden 3.4 compare
- 75 Switzerland 3.4 compare
- 75 Tuvalu 3.4 compare
- 75 Yemen 3.4 compare
More reference data data for Syria
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.1191 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 4.23 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 7.23 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.5377 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 7.23 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.3995 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.1542 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 16.14 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 29.26 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 2.93 (2050)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Syria?
- Statin use vs. average non-hdl cholesterol levels in Syria was 3.4 in 2018, according to World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Syria?
- The highest recorded value was 3.7 in 1998.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Syria?
- The lowest recorded value was 3.3 in 1980.
- How does Syria rank for statin use vs. average non-hdl cholesterol levels?
- Syria ranks 75th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Syria?
- Over the last ten years it is down 5.6%. The long-run trend across the full record is flat.
- Where does this Syria data come from?
- The figures come from World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.